Peer review reports
From: Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer
Original Submission |
26 Jun 2023 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
2 Aug 2023 |
Reviewed |
Reviewer Report
|
15 Sep 2023 |
Reviewed |
Reviewer Report
|
28 Oct 2023 |
Author responded |
Author comments - Liping Dai
|
Resubmission - Version 4 |
28 Oct 2023 |
Submitted |
Manuscript version 4
|
30 Oct 2023 |
Author responded |
Author comments - Liping Dai
|
Resubmission - Version 5 |
30 Oct 2023 |
Submitted |
Manuscript version 5
|
1 Nov 2023 |
Author responded |
Author comments - Liping Dai
|
Resubmission - Version 6 |
1 Nov 2023 |
Submitted |
Manuscript version 6
|
4 Nov 2023 |
Author responded |
Author comments - Liping Dai
|
Resubmission - Version 7 |
4 Nov 2023 |
Submitted |
Manuscript version 7
|
9 Nov 2023 |
Author responded |
Author comments - Liping Dai
|
Resubmission - Version 8 |
9 Nov 2023 |
Submitted |
Manuscript version 8
|
5 Dec 2023 |
Reviewed |
Reviewer Report
|
Resubmission - Version 9 |
|
Submitted |
Manuscript version 9
|
Publishing |
18 Feb 2024 |
Editorially accepted |
|
2 Mar 2024 |
Article published |
10.1186/s12885-024-12019-w
|
Learn about peer review